Position in MIRA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$287,775
-$23,476 QoQ
Shares Held
303,882
+4.5% QoQ
Ownership
0.723%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 26 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MIRA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $76,028,444,777 across 14 Drug Manufacturers - General names. MIRA ranks #13 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,310,858 | $24,361,454,441 | |
| 2 | JNJ |
Johnson & Johnson
|
59,086,417 | $15,006,177,324 | |
| 3 | ABBV |
AbbVie Inc.
|
46,998,433 | $11,826,685,679 | |
| 4 | MRK |
Merck & Co., Inc.
|
60,744,214 | $7,805,631,499 | |
| 5 | AMGN |
Amgen Inc
|
15,696,068 | $5,683,860,144 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
30,065,642 | $3,798,493,209 | |
| 7 | PFE |
Pfizer Inc
|
135,275,782 | $3,257,440,829 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
56,443,077 | $3,252,250,096 |
All Filings in MIRA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $287,775 | 303,882 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $311,251 | 290,890 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $412,045 | 272,878 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $185,557 | 136,440 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $163,705 | 135,295 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $132,709 | 135,418 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $139,177 | 122,086 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $150,688 | 115,914 | Shares | Defined | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||